Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-RFA-CK-22-003, Emerging Infections Sentinel Networks (EISN) Research; Amended Notice of Meeting

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published

December 3, 2021

Issuing agencies

Health and Human Services DepartmentCenters for Disease Control and Prevention

Full Text

<html>
<head>
<title>Federal Register, Volume 86 Issue 230 (Friday, December 3, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 230 (Friday, December 3, 2021)]
[Notices]
[Page 68671]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-26298]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP)--RFA-CK-22-003, Emerging Infections Sentinel 
Networks (EISN) Research; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the Disease, 
Disability, and Injury Prevention and Control Special Emphasis Panel 
(SEP)--RFA-CK-22-003, Emerging Infections Sentinel Networks (EISN) 
Research; January 11, 2022, 10:00 a.m.-5:00 p.m., EST, Teleconference, 
Centers for Disease Control and Prevention, Room 1080, 8 Corporate 
Square Boulevard, Atlanta, Georgia 30329-4027, in the original FRN. The 
meeting was published in the Federal Register on November 8, 2021, 
Volume 86, Number 213, page 61767.
    The meeting is being amended to change the contact information and 
should read as follows:

FOR FURTHER INFORMATION CONTACT: Gregory Anderson, M.S., M.P.H., 
Scientific Review Officer, National Center for HIV, Viral Hepatitis, 
STD, and TB Prevention, CDC, 1600 Clifton Road NE, Mailstop US8-1, 
Atlanta, Georgia 30329-4027, Telephone: (404) 718-8833; Email: 
<a href="/cdn-cgi/l/email-protection#6027210e040512130f0e200304034e070f16"><span class="__cf_email__" data-cfemail="2c6b6d4248495e5f43426c4f484f024b435a">[email&#160;protected]</span></a>.
    The meeting is closed to the public.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-26298 Filed 12-2-21; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>

View on FederalRegister.gov →Plain-text source

Indexed from Federal Register on December 3, 2021.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.